Bela2-microglobuline amyloidosis: Fibrillogenesis of natural and recombinant human beta2-microglobulines
- Authors: Poyakov DS1, Grudinina NA1, Solovyov KV1, Egorov VV1, Sirotkin AK1, Aleinicova TD1, Totolian A.A1, Shavlovsky MM1
-
Affiliations:
- Issue: Vol 10, No 2 (2010)
- Pages: 40-49
- Section: Articles
- URL: https://journals.eco-vector.com/MAJ/article/view/10067
- DOI: https://doi.org/10.17816/MAJ10240-49
- ID: 10067
Cite item
Full Text
Abstract
Full Text
About the authors
D S Poyakov
Email: dipoi@mail.org
N A Grudinina
K V Solovyov
V V Egorov
A K Sirotkin
T D Aleinicova
Areg A Totolian
M M Shavlovsky
References
- Брок Й. Получение препаратов иммуноглобулинов // Иммунологические методы / Г. Фримель. М.: Медицина, 1987. С. 390.
- Ермоленко В.М. Хроническая почечная недостаточность // Нефрология: Руководство для врачей / Под ред. Іі.Е. Тареевой. М.: Медицина, 2000. С. 633- 634.
- Харбоу Н., Ингильд А. Иммунизация, выделение иммуноглобулинов, определение титра антител // Руководство по клиническому электрофорезу. М.: Мир, 1977. С. 200-205.
- Шило В., Денисов А. Позднее осложнение программного гемодиализа: бета-2-микроглобулиновый амилоидоз // Врач : Ежемесячный научно-практический и публицистический журнал. 2002. № 6. С. 7-12.
- Guideline 10. p2-microglobulin amyloidosis // Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease / Massry S.G., Cobum J.W. // Am. J. Kidney Dis. 2003. Vol. 42 (Suppl. 3). P. 1-202.
- Ausubel F.M., Brent R., Kingston R.E. et al. // Current Protocols in Molecular Biology. 1989. John Wiley & Sons, New York.
- Benz R.L., Siegfried J.W., Teehan B.P. Carpal tunnel syndrome in dialysis patients: Comparison between continuous ambulatory peritoneal dialysis and hemodialysis populations //Am.1. Kidney Dis. 1988. № 11. P. 473-476.
- Berggard I., Beam A.G. Isolation and properties of a low molecular weight B2-globulin occurring in human biological fluids // J. Biol. Chem. 1968. № 243. P. 4095-4103.
- Campistol J.M., Sole M., Munoz-Gomez J., Lopez-Pedret J., Revert L. Systemic involvement of dialysis-amyloidosis //Am. J. Nephrol. 1990. № ю. P. 389-396.
- Chiba T., Hagihara Y., Higurashi T., Hasegawa K., Nai- lci H., Goto Y. Amyloid fibril formation in the context of full-length protein. Effects of proline mutations on the amyloid fibril formation of B2-microglobulin // J. Biol. Chem. 2003. № 278. P. 47016-47024.
- Comelis F., Bardin T., Faller B. et al. Rheumatic syndromes and beta 2-microglobulin amyloidosis in patients receiving long-term peritoneal dialysis // Arthritis Rheum. 1989. № 32. P. 785-788.
- Esposito G., Michelutti R., Verdone G. et al. Removal of the N-terminal hexapeptide from human b2-micro- globulin facilitates protein aggregation and fibril formation // Protein Sci. 2000. № 9. P 831-845.
- Gal R., Korzets A., Schwartz A., Rath-Wolfson L., Gafter U. Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo longterm hemodialysis. Report of seven cases and review of the literature // Arch. Pathol. Lab. Med. 1994. № 118. P. 718-721.
- Goldsby R.A., Kindt T.J., Osborne B.A. Major histocompatibility complex // Kuby Immunology / Freeman W.H. 2007. P. 166-178.
- Jadoul M., Garbar C., Noel H., Sennesael J., Vanholder R., Bemaert P, Rorive G., Hanique G., van Ypersele, de Strihou C. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study // Kidney Int. 1997 (Jun). Vol. 51 (6). P. 1928-1932.
- Kad N.M., Thomson N.H., Smith D.P., Smith D.A., Radford S.E. // J. Mol. Biol. 2001. № 313. P. 559- 571.
- Kayed R.K., Glabe C.G. Conformation-Dependent Anti-Amyloid Oligomer Antibodies // Methods in enzymology. 2006. Vol. 413. P. 326-344.
- Kihara M., Chatani E., Sakai M., Hasegawa K., Naiki H., Goto Y. Seeding-dependent maturation of (32- microglobulin amyloid fibrils at neutral pH // J. Biol. Chem. 2005. № 280. P. 12012-12018.
- LeVine H. Thioflavine T interaction with synthetic Alzheimer’s disease b-amyloid peptides: detection amyloid aggregation in solution // Prot. Sci. 1993. № 2. P. 404M10.
- Maruyama Н., Gejyo F., Aralcawa M. Clinical studies of destructive spondyloarthropathy in long-term hemodialysis patients //Nephron. 1992. № 61. P. 37- 44.
- McParland V.J., Kad N.M., Kalverda A.P., Brown A., Kirwin-Jones P., Hunter M. G., Sunde M., Radford S.E. // Biochemistry. 2000. № 39. P. 8735-8746.
- Moriniere P., Marie A., el Esper N., Fardellone P., Derarnond H., Remond A., Sebert J.L., Fournier A. Destructive spondyloarthropathy with beta 2-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis //Nephron. 1991. № 59. P. 654-657.
- Ohashi К., Нага M., Kawai R., Ogura Y., Flonda K., Nihei H., Mimura N. Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column // Kidney Int. 1992. № 41. P. 1646- 1652.
- Pedelacq J.D., Cabantous S., Tran T., Terwilliger T.C., Waldo G.S. Engineering and characterization of a superfolder green fluorescent protein // Nat. Biotechnol. 2006. Vol. 24. № 1. P. 79-88.
- Sasahara K., Yagi H., Naiki FI., Goto, Y. Heat-triggered conversion of protofibrils into mature amyloid fibrils of (32-microglobulin // Biochemistry. 2007. № 46. P. 3286-3293.
- Sasahara K., Yagi H., Naiki H., Goto Y. Heat-induced conversion of (32-microglobulin and hen egg-white lysozyme into amyloid fibrils // J. Mol. Biol. 2007. № 372. P. 981-991.
- Sprague S.M., Мое S.M. Clinical manifestations and pathogenesis of dialysis-related amyloidosis // Semin. Dial. 1996. №9. P.360-369.
- Ventura S., Villaverde A. Protein quality in bacterial inclusion bodies // Trends Biotechnol. 2006. № 24. P. 179-185.
- Zingraff J.J., Noel L.H., Bardin T., Atienza C., Zins B., Drueke T.B., Kuntz D. Beta 2-microglobulin amyloidosis in chronic renal failure // N. Engl. J. Med. 1990. № 323. P. 1070-1071.